Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Zhongning Pharmaceutical Co., Ltd. (广西忠宁制药有限公司) is a commercial-stage Chinese pharmaceutical company specializing in the manufacture and commercialization of traditional Chinese patent medicines (TCPM) and chemical drug preparations. Established in August 1999 and headquartered in Nanning, Guangxi, the company produces a variety of dosage forms, including tablets, granules, capsules, mixtures, and external-use liniments. Its product portfolio features widely used over-the-counter (OTC) treatments such as Ganmaoling Granules (感冒灵颗粒), Xiaosangju Granules (夏桑菊颗粒), and Honghua Oil (红花油) for indications like the common cold, fever, and pain relief. In recent years, the company has faced significant regulatory enforcement from the Guangxi Medical Products Administration due to compliance and quality control issues, leading to severe administrative penalties and leadership bans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Zhongning Pharmaceutical.